With Clostridium Difficile Infections: Observational Data Of The - - PowerPoint PPT Presentation

with clostridium difficile
SMART_READER_LITE
LIVE PREVIEW

With Clostridium Difficile Infections: Observational Data Of The - - PowerPoint PPT Presentation

Management Of Elderly Patients With Clostridium Difficile Infections: Observational Data Of The French Survey CLOdi Arnaud CAUPENNE, Gaetan GAVAZZI, Marc PACCALIN University of Poitiers, FRANCE Intergroupe GInGer CONFLICT OF INTEREST


slide-1
SLIDE 1

Management Of Elderly Patients With Clostridium Difficile Infections: Observational Data Of The French Survey CLOdi

Arnaud CAUPENNE, Gaetan GAVAZZI, Marc PACCALIN University of Poitiers, FRANCE Intergroupe GInGer

slide-2
SLIDE 2

CONFLICT OF INTEREST DISCLOSURE

I have no potential conflict of interest to report

slide-3
SLIDE 3

BACKGROUND

  • First cause of nosocomial diarrhea
  • Incidence: 2.28/10000 hospitalized patients-day (national french

study)

Eckert, 2013

  • Recurrence and mortality estimated respectively 10 to 30% and

5 to 40%

Surawicz, 2015 ; Garey, 2008 ; Johnson, 2009

  • Assessment of risk factors and therapeutic practices for severe

CDI are heterogeneous.

Abou Chakra, 2014 ; Le Guern, 2013 ; Surawicz, 2013 ; Debast, 2014

slide-4
SLIDE 4

RECOMMANDATIONS ESCMID 2013

slide-5
SLIDE 5

AIMS

  • To assess prognosis of elderly patients with CDI
  • To report observational data collected during hospitalization

and therapeutic regimen regarding to the European recommendations

slide-6
SLIDE 6

PATIENTS AND METHODS

  • French survey CLOdi: prospective observational multicentric

study

  • Inclusions: hospitalized patients aged ≥75 with CDI
  • 70 investigators in 31 French hospital centers
  • Inclusion: between march 2016 and may 2017
  • Online survey focused on clinical criteria of severity, and CDI

therapeutic support

  • Systematic follow-up at 3 months
slide-7
SLIDE 7

PRELIMINARY RESULTS

Characteristics of the population

  • 260 patients
  • Mean age: 87.1 ± 5.5 [75-99]
  • Female: 65%
  • Coming from home (83%) and nursing home (17%)
  • CIRS-G score: 12.54 ± 6.4 [2-34] (comorbidities)
  • 71% hospitalized in the past 12 months
  • 60% treated with antibiotic in the last 3 months
slide-8
SLIDE 8

Characteristics of the infection

  • Nosocomial: 68.2%
  • At the time of diagnosis
  • Diarrhea: 88%
  • Antibiotic: 44% among 60.5% were stopped
  • Control measure
  • isolation precaution: 94.5%

RESULTS

slide-9
SLIDE 9

Severity criteria N (%) Fever > 38,5°C 44 (16.9%) Rigors 8 (3.1%) Sepsis 12 (4.6%) Leucocyte count > 15 x 109/L 74 (28.5%) Créatinine > 50% above the baseline 53 (20.4%) Albumin < 30 g/L 135 (51.9%) Kalemia < 3,5 mmol/L 52 (20%) Distension of large intestine > 6 cm 1 (0.4%) Pseudomembranous colitis 6 (2.3%) Septic shock 3 (1.2%) Ileus 6 (2.3%)

SEVERITY

197 (75,7%) patients with at least one severity marker (ESCMID)

slide-10
SLIDE 10

FIRST INTENTION TREATMENT

[VALORE] (51.2%) [VALORE] (36.9%) [VALORE] (10%) [VALORE] (1.2%)

20 40 60 80 100 120 140

Metronidazol Vancomycin Fidaxomicin Association of antibiotics

Nbr patients Antibiotics

slide-11
SLIDE 11

EVOLUTION

Mean duration of isolation precaution (days) 11.8 ± 9.73 [0-82] Mean duration of antibiotic therapy (days) 11.6 ± 5.78 [0-67] Healing 187 (71.9%) Surgery 1 (0.4%) Death

  • Death during the antibiotic treatment
  • Death after the infection

45 (17.3%)

21 (8.1%) 24 (9.2%)

In-hospitalization recurrence 31 (11.9%)

slide-12
SLIDE 12

CONCLUSION

  • Our study shows high rate of severe infection in older patients
  • Metronidazol is the first intention therapy in 51% cases
  • Rate of early recurrence and mortality are close to literature

data

  • The results highlight the lack of adequacy between antibiotic

used and the European guidelines

slide-13
SLIDE 13

Thanks to investigators

PARIS Dr Moulias Pr Rouveix Dr Greffe Dr Breining Dr Durand-Gasselin TREVOUX Dr Pietropaoli Dr Marechal DIJON Pr Piroth Dr Putot AIX Dr Puigserver Dr Maulin ROUEN Dr Renaudier Dr Guignery-Kadri Dr Kloul LYON Dr Federico Dr Gaujard Dr Martin Gaujard Dr Albrand Dr Chala hayet ALES Dr Fraisse MONTPELLIER Dr Terminet Pr Jeandel ANGERS Dr Tremblay Nguyen Dr Pignon NICE Dr Turpin Dr Mondain Dr Arlaud CLERMONT FERRAND Dr Dadet COLMAR Dr Dardalhon Dr Hauler SAINT ETIENNE Dr Dascalita

NIMES Pr de Wazieres (invest) Dr Viala Maurice (invest)

TOURS Pr Bernard Dr Lamande ORLEANS Dr Bourgeois BLOIS Dr Geffroy Dr Friocourt PERPIGNAN Dr Eden Dr Silga CHAMBERY Dr Forestier GRENOBLE Dr Pavese Pr Gavazzi ANNECY Dr Piet ROCHEFORT Dr Chartier CHATELLERA ULT Dr Gazali NIORT Dr Kahlifa SAINT YVI Dr Jestin BORDEAUX Dr Bourdel-Marchasson Dr Dubos VENDEE Dr Pelerin Dr Martin Dr Fevrier Dr Decours Dr Guimard Dr Morier Saint GALMIER Dr Carriere PLAISIR Dr Aribi BELLEY Dr Bard DUNKERQUE Dr Berode DIEPPE Dr Suel LANDERNEAU Dr Merrien ANGOULEME Dr Jarry